On the recordApril 27, 2015
I wanted to ask you, in the context of rare pediatric diseases--I understand that FDA recently awarded the third and final priority review voucher as authorized under FDASIA.
Source
congress.govI wanted to ask you, in the context of rare pediatric diseases--I understand that FDA recently awarded the third and final priority review voucher as authorized under FDASIA.
Senator Casey discusses FDA's priority review vouchers for rare pediatric diseases.
Share
More from Bob Casey
I am disappointed that Dr. de la Torre defied the subpoena this Committee authorized and has chosen not to appear today.
We are enormously grateful for leaders like Senator Casey who are working to make those investments a reality.
They're selling you a lie. It's in the bag with the diapers. Prices are up because these corporations are scheming to drive them up.